Asia Pacific Neurovascular Devices Market Size & Outlook

The neurovascular devices market in Asia Pacific is expected to reach a projected revenue of US$ 3,074.9 million by 2033. A compound annual growth rate of 6.7% is expected of Asia Pacific neurovascular devices market from 2025 to 2033.
Revenue, 2024 (US$M)
$1,698.9
Forecast, 2033 (US$M)
$3,074.9
CAGR, 2025 - 2033
6.7%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific neurovascular devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific neurovascular devices market highlights

  • The Asia Pacific neurovascular devices market generated a revenue of USD 1,698.9 million in 2024.
  • The market is expected to grow at a CAGR of 6.7% from 2025 to 2033.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device type in 2024.
  • Cerebral Embolization and Aneurysm Coiling Devices is the most lucrative device type segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2025 to 2033.


Asia Pacific data book summary

Market revenue in 2024USD 1,698.9 million
Market revenue in 2033USD 3,074.9 million
Growth rate6.7% (CAGR from 2025 to 2033)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentCerebral Embolization and Aneurysm Coiling Devices
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp, Acandis GmbH, Spiegelberg, Zylox


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.1% of the global neurovascular devices market in 2024.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,074.9 million by 2033.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 42.95% in 2024. Horizon Databook has segmented the Asia Pacific neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2021 to 2033.


Asia Pacific neurovascular devices market is majorly driven by increasing incidence of acute ischemic stroke. In addition, emerging economies such as China, Japan, South Korea, and India are expected to witness considerable growth over the forecast period. 

Presence of several local players in China and Japan is expected to boost the market growth. Rising awareness about neurological disease treatment options and improvements in clinical development framework of emerging economies are expected to drive the market growth.

Furthermore, establishment of organizations such as the Asia-Pacific Centre for Neuromodulation (APCN), which is founded for conducting research and promoting awareness about associated benefits of deep brain stimulation surgeries, is anticipated to boost market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website
Zylox View profile 501-1000 Hangzhou, Zhejiang, China, Asia http://www.zyloxmedical.com/
Acandis GmbH View profile 251-500 Pforzheim, Baden-Wurttemberg, Germany, Europe https://www.acandis.com/start-1-en
Spiegelberg View profile 11-50 Hamburg, Hamburg, Germany, Europe https://www.spiegelberg.de/en/
Penumbra Inc View profile 4200 One Penumbra Place, Alameda, CA, United States, 94502 https://www.penumbrainc.com
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Asia Pacific neurovascular devices market size, by country, 2021-2033 (US$M)

Asia Pacific Neurovascular Devices Market Outlook Share, 2024 & 2033 (US$M)

Asia Pacific neurovascular devices market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online